Immunogenicity and Safety of MMRV and PCV-7 Administered Concomitantly in Healthy Children

Abstract

Concomitant administration of the MMRV and PCV-7 is highly immunogenic and generally well tolerated. Similar immune responses between the groups support concomitant administration of the MMRV and PCV-7 to healthy children 12 to 15 months of age.